deficiencia 1 517 1 9598,	
galactosemia) 1 517 1 9596,	
galactosa 2 517 2 9589,9593,	
glucosa 1 517 1 9586,	
malabsorción 2 517 2 9584,9587,	
isomaltasa 1 517 1 9579,	
déficit 2 517 2 9574,9577,	
contienen 1 517 1 9563,	
(hidroxi-metil-glutaril)-CoA 1 517 1 9212,	
presentar 1 517 1 8850,	
debería 1 517 1 8155,	
17 1 517 1 7956,	
recomendado 1 517 1 7924,	
confirmar 1 517 1 7914,	
formulaciones 1 517 1 7906,	
ó 1 517 1 7898,	
formulación 2 517 2 7874,7881,	
cambiados 1 517 1 7871,	
(n=167) 1 517 1 7541,	
proporcionaron 1 517 1 7532,	
partido 1 517 1 7105,	
masticado 1 517 1 7103,	
machacado 1 517 1 7102,	
haberse 1 517 1 7101,	
determinado 1 517 1 7094,	
" 1 517 1 6997,	
mg"" 1 517 1 6996,	
cara 1 517 1 6993,	
grabado 1 517 1 6990,	
lleva 1 517 1 6989,	
blanco 1 517 1 6987,	
color 1 517 1 6986,	
triangular 1 517 1 6984,	
Comprimido 1 517 1 6982,	
recubierto 2 517 2 6981,6983,	
comprimido 1 517 1 6959,	
recubiertos 1 517 1 6952,	
comprimidos 6 517 6 6951,7099,7518,7883,7912,9560,	
europa 1 517 1 6942,	
emea 1 517 1 6941,	
//www 1 517 1 6940,	
http 1 517 1 6939,	
Europea 1 517 1 6935,	
web 1 517 1 6931,	
página 1 517 1 6930,	
detallada 1 517 1 6922,	
TEXTO 1 517 1 6919,	
2006 1 517 1 6912,	
15 1 517 1 6908,	
revalidación 1 517 1 6907,	
última 1 517 1 6906,	
2001 1 517 1 6902,	
autorización 1 517 1 6897,	
Fecha 2 517 2 6894,6903,	
AUTORIZACIÓN/RENOVACIÓN 1 517 1 6890,	
PRIMERA 1 517 1 6889,	
FECHA 2 517 2 6886,6914,	
EU/1/01/171/001 1 517 1 6884,	
NÚMERO(S) 1 517 1 6879,	
Unido 1 517 1 6877,	
Maidenhead 1 517 1 6872,	
South 1 517 1 6870,	
Lane 1 517 1 6869,	
Ltd 1 517 1 6867,	
Europa 1 517 1 6866,	
	Wyeth 1 517 1 6865,	
COMERCIALIZACIÓN 2 517 2 6864,6883,	
AUTORIZACIÓN 3 517 3 6862,6881,6893,	
LA 4 517 4 6861,6888,6892,6916,	
ml) 1 517 1 6844,	
adicional 1 517 1 6840,	
recipiente 1 517 1 6836,	
Rellenar 1 517 1 6834,	
beber 2 517 2 6830,6854,	
vigorosamente 2 517 2 6828,6852,	
Agitar 1 517 1 6827,	
incluido 1 517 1 6822,	
líquidos 1 517 1 6821,	
vaso 1 517 1 6791,	
correcta 1 517 1 6783,	
Vaciar 1 517 1 6780,	
prescrita 1 517 1 6774,	
extraer 1 517 1 6771,	
dosificadora 1 517 1 6767,	
Instrucciones 1 517 1 6759,	
locales 1 517 1 6758,	
contacto 1 517 1 6748,	
hayan 1 517 1 6745,	
manipulaciones 1 517 1 6732,	
topacio 1 517 1 6709,	
vidrio 2 517 2 6708,6793,	
Botellas 1 517 1 6706,	
Naturaleza 1 517 1 6701,	
horas) 1 517 1 6698,	
corto 1 517 1 6693,	
botellas 1 517 1 6684,	
protegerlo 1 517 1 6672,	
original 1 517 1 6670,	
botella 2 517 2 6669,6779,	
8º 1 517 1 6664,	
C 2 517 2 6662,6690,	
2º 1 517 1 6661,	
(entre 1 517 1 6660,	
Conservar 2 517 2 6657,6666,	
conservación 1 517 1 6656,	
6) 1 517 1 6645,	
Taplow 1 517 1 6871,	
25º 2 517 2 6636,6689,	
sobrepasar 1 517 1 6634,	
ambiente 2 517 2 6631,6687,	
temperatura 2 517 2 6630,6686,	
(a 1 517 1 6629,	
dosificadoras 1 517 1 6626,	
abierto 1 517 1 6620,	
Frasco 1 517 1 6619,	
validez 1 517 1 6616,	
dilución 3 517 3 6604,6641,6816,	
plástico 3 517 3 6601,6723,6795,	
inmediatamente 2 517 2 6592,6650,	
instrucciones 1 517 1 6589,	
considerar 1 517 1 6587,	
importante 1 517 1 6586,	
vinilo 1 517 1 6580,	
Etilhexil)ftalato 1 517 1 6573,	
Precauciones 3 517 3 6551,6653,6726,	
diluido 1 517 1 6532,	
ascorbilo) 1 517 1 6524,	
palmitato 1 517 1 6522,	
soja 1 517 1 6520,	
grasos 1 517 1 6518,	
ácidos 1 517 1 6517,	
5%) 1 517 1 6516,	
5% 1 517 1 6513,	
etanol 1 517 1 6511,	
diglicéridos 1 517 1 6510,	
monoglicéridos 1 517 1 6509,	
propilenglicol 1 517 1 6508,	
PG 1 517 1 6506,	
Phosal 1 517 1 6504,	
80 2 517 2 6503,6563,	
Polisorbato 1 517 1 6502,	
Lista 1 517 1 6499,	
FARMACÉUTICOS 1 517 1 6496,	
Ver 2 517 2 6490,6550,	
esquelética) 1 517 1 6489,	
osificación 1 517 1 6488,	
retrasos 1 517 1 6484,	
fetos 1 517 1 6482,	
mortalidad 1 517 1 6475,	
manifestó 1 517 1 6473,	
embrio/fetotoxicidad 1 517 1 6470,	
provocó 1 517 1 6469,	
monos 1 517 1 6465,	
gigantes 1 517 1 6454,	
materiales 1 517 1 6743,	
atrofia 1 517 1 6450,	
histológicas 1 517 1 6447,	
espermatozoides 1 517 1 6435,	
recuentos 1 517 1 6433,	
parcialmente 1 517 1 6429,	
13 1 517 1 6424,	
macho 1 517 1 6417,	
reproducción 1 517 1 6407,	
importancia 1 517 1 6398,	
consideran 1 517 1 6396,	
normalmente 1 517 1 6394,	
luteinizante 1 517 1 6392,	
hormona 1 517 1 6391,	
especie 1 517 1 6385,	
dependiente 1 517 1 6382,	
indicativos 1 517 1 6378,	
probablemente 1 517 1 6376,	
testiculares 1 517 1 6375,	
intersticiales 1 517 1 6374,	
adenomas 1 517 1 6372,	
crónica 1 517 1 6368,	
relacionados 1 517 1 6364,	
lesiones 2 517 2 6356,6446,	
observados 1 517 1 6345,	
crónico 1 517 1 6338,	
secundarios 1 517 1 6334,	
(linfomas) 1 517 1 6333,	
esperarse 1 517 1 6331,	
conocido 1 517 1 6328,	
vasos 1 517 1 6798,	
Es 1 517 1 6327,	
hembra) 1 517 1 6326,	
granulocítica 1 517 1 6324,	
leucemia 1 517 1 6323,	
adenoma 1 517 1 6315,	
hembras) 1 517 1 6314,	
machos 1 517 1 6312,	
(ratones 3 517 3 6311,6319,6325,	
linfomas 1 517 1 6310,	
incidencias 1 517 1 6308,	
ratones 2 517 2 6300,6353,	
cabo 1 517 1 6298,	
llevados 1 517 1 6296,	
carcinogenicidad 1 517 1 6295,	
Estudios 1 517 1 6293,	
micronúcleos 1 517 1 6290,	
ratón 2 517 2 6282,6292,	
hámster 1 517 1 6268,	
ovario 1 517 1 6266,	
aberración 1 517 1 6261,	
bacterias 1 517 1 6254,	
inversa 1 517 1 6252,	
mutación 2 517 2 6251,6276,	
mutagénico 1 517 1 6247,	
pulmonar 1 517 1 6243,	
fosfolipidosis 1 517 1 6242,	
hematopoyesis 1 517 1 6239,	
cromosómica 1 517 1 6262,	
óseas 1 517 1 6238,	
callosidades 1 517 1 6237,	
tubular 2 517 2 6229,6451,	
degeneración 1 517 1 6228,	
islotes 1 517 1 6224,	
repercusión 1 517 1 6214,	
detectadas 1 517 1 6200,	
preclínicos 1 517 1 6188,	
Datos 1 517 1 6187,	
diálisis) 1 517 1 6184,	
(pacientes 1 517 1 6181,	
ausente 1 517 1 6180,	
varía 1 517 1 6176,	
semividaobservada 1 517 1 6147,	
67 1 517 1 6131,	
170 1 517 1 6120,	
43 1 517 1 6074,	
61 1 517 1 6070,	
ulceración 1 517 1 6233,	
t1/2 2 517 2 6065,6111,	
B) 1 517 1 6057,	
Child-Pugh 2 517 2 6054,6102,	
(Clasificación 2 517 2 6052,6100,	
moderada 1 517 1 6051,	
individuos 1 517 1 6037,	
adaptador 1 517 1 6716,	
gran 1 517 1 6033,	
mayores 2 517 2 6022,7528,	
ml/h/kg) 3 517 3 6017,6024,6030,	
(580 1 517 1 6016,	
menor 1 517 1 6014,	
peso 2 517 2 6007,6479,	
normalizado 1 517 1 6004,	
CL/F 2 517 2 6003,6081,	
50 2 517 2 5972,6505,	
- 1 517 1 5971,	
(con 2 517 2 5967,6483,	
respecto 1 517 1 5939,	
diluir 1 517 1 5933,	
agua 4 517 4 5931,6545,6809,6846,	
(AUC) 1 517 1 5909,	
(tmáx 1 517 1 5897,	
(Cmáx 1 517 1 5881,	
34 1 517 1 5871,	
produjo 1 517 1 5867,	
líquido 2 517 2 5864,6541,	
características 1 517 1 5859,	
observaron 2 517 2 6427,6437,	
alteró 1 517 1 5857,	
contenido 2 517 2 5854,6703,	
alimentación 1 517 1 5851,	
responderían 1 517 1 5804,	
pequeña 1 517 1 5778,	
excretó 1 517 1 5776,	
heces 1 517 1 5772,	
%) 2 517 2 5767,5782,	
(91 1 517 1 5765,	
recuperó 1 517 1 5761,	
[14C]sirolimus 1 517 1 5756,	
90 1 517 1 5744,	
constituye 1 517 1 5741,	
componente 1 517 1 5734,	
hidroxilo 1 517 1 5727,	
210 1 517 1 6116,	
principales 1 517 1 5725,	
siete 1 517 1 5723,	
identificaron 1 517 1 5722,	
hidroxilación 1 517 1 5717,	
O-desmetilación 1 517 1 5715,	
metaboliza 1 517 1 5712,	
IIIA 1 517 1 5704,	
diversas 1 517 1 6170,	
n=219) 1 517 1 5684,	
22 1 517 1 5676,	
grasa 1 517 1 5856,	
cromatográfico; 2 517 2 5659,5683,	
expresado 2 517 2 5654,5678,	
ng/mL 1 517 1 5653,	
LC-SM/SM) 1 517 1 5606,	
partir 2 517 2 5600,6576,	
calculados 1 517 1 5598,	
ml/h/kg 1 517 1 5596,	
72 1 517 1 5595,	
pediátricos 3 517 3 5963,6012,6021,	
182 1 517 1 5593,	
ng·h/ml 1 517 1 5591,	
70 1 517 1 5590,	
158 1 517 1 5588,	
AUCt 1 517 1 5586,	
ss 3 517 3 5571,5579,5587,	
III 3 517 3 5568,5643,6711,	
clínico 2 517 2 5565,6218,	
diarias 1 517 1 5555,	
Rapamune) 1 517 1 5549,	
(4 2 517 2 5545,5649,	
19 2 517 2 5536,9119,	
Cl/F 1 517 1 6127,	
farmacocinéticos 2 517 2 5531,6164,	
celulares 2 517 2 5525,6373,	
elementos 1 517 1 5524,	
ampliamente 2 517 2 5521,5713,	
distribuye 1 517 1 5520,	
(450 1 517 1 6023,	
alcanzaron 1 517 1 5500,	
medias 1 517 1 5494,	
corta 1 517 1 5490,	
embargo 1 517 1 5484,	
Sin 1 517 1 5483,	
h 2 517 2 5482,5585,	
16 1 517 1 5481,	
repetida 1 517 1 5451,	
14 3 517 3 5446,5671,6898,	
(Sandimmun) 1 517 1 5441,	
sistémica 1 517 1 5431,	
disponibilidad 1 517 1 5430,	
únicas 1 517 1 5414,	
hora 1 517 1 5407,	
pico 3 517 3 5404,5876,5896,	
daclizumab 1 517 1 5381,	
evitarse 1 517 1 5960,	
utilizó 1 517 1 5374,	
mejor 1 517 1 5354,	
numéricamente 1 517 1 5322,	
antagonista 2 517 2 5305,5340,	
(MMF) 1 517 1 5301,	
multicéntricos 1 517 1 5288,	
éste 1 517 1 5282,	
vio 1 517 1 5272,	
correspondiente 1 517 1 5242,	
convertidos 1 517 1 5235,	
normal 2 517 2 5220,6178,	
urinaria 1 517 1 5219,	
9%) 1 517 1 5201,	
melanóticas 1 517 1 5174,	
comparados 1 517 1 5133,	
continuó 2 517 2 5130,5191,	
orina 2 517 2 5121,5784,	
ratios 1 517 1 5118,	
dieron 1 517 1 5084,	
emergentes 1 517 1 5078,	
mejoró 1 517 1 5054,	
eventos 1 517 1 5033,	
<40 2 517 2 5025,5109,	
cuya 3 517 3 5022,5045,5106,	
estrato 3 517 3 5019,5042,5103,	
trasplante) 1 517 1 5000,	
evaluó 1 517 1 4973,	
mL/min) 1 517 1 4971,	
MMF 1 517 1 5336,	
(20-40 1 517 1 4967,	
fracturas 1 517 1 6235,	
inicio 1 517 1 4964,	
FG 6 517 6 4961,5023,5046,5107,5211,5222,	
aleatorizado 1 517 1 4952,	
Mediante 1 517 1 4949,	
retrasó 1 517 1 4947,	
suceso 1 517 1 4945,	
>40 3 517 3 4970,5048,5212,	
carcinoma 2 517 2 4936,6318,	
(8 2 517 2 4928,5673,	
continuaron 3 517 3 4908,5137,5246,	
cohorte 2 517 2 4904,4916,	
neoplasias 2 517 2 4895,5171,	
quitar 1 517 1 4878,	
sanguínea 1 517 1 4865,	
presión 1 517 1 4864,	
creciente 1 517 1 4849,	
análisis 1 517 1 4837,	
elevada 2 517 2 4810,4901,	
respectivamente) 2 517 2 4778,4933,	
8% 3 517 3 4774,4932,5198,	
(9 1 517 1 4773,	
pancreáticas 1 517 1 6227,	
comparado 2 517 2 4756,5186,	
biopsia 1 517 1 4747,	
confirmado 1 517 1 4745,	
primer 2 517 2 4740,4944,	
seguimiento) 1 517 1 4732,	
seguido 2 517 2 4709,4817,	
favor 1 517 1 4704,	
estadísticamente 1 517 1 4696,	
hubo 2 517 2 4693,5608,	
48 2 517 2 4691,4803,	
grupos 2 517 2 4688,4784,	
similar 1 517 1 4685,	
supervivencia 3 517 3 4678,4700,4853,	
recomiendan 1 517 1 4664,	
inadecuada 1 517 1 4629,	
micromoles/l 1 517 1 4622,	
>400 1 517 1 4621,	
""RAPAMUNE 1 517 1 6994,	
Banff 1 517 1 4609,	
Grado 1 517 1 4607,	
agudos 1 517 1 4605,	
episodios 1 517 1 4602,	
sobrevivieron 1 517 1 4583,	
anteriores 1 517 1 4582,	
injertos 1 517 1 4581,	
proteína/creatinina 1 517 1 5119,	
cuyos 1 517 1 4580,	
re-trasplante 1 517 1 4579,	
muerto 1 517 1 4573,	
donante 1 517 1 4570,	
aloinjerto 1 517 1 4566,	
incluyó 2 517 2 4561,5007,	
ciclosporina-mantenimiento 2 517 2 4557,4658,	
fase 3 517 3 4552,5567,5642,	
presentaron 1 517 1 4541,	
estudiaron 2 517 2 4538,4648,	
(S/P) 1 517 1 5513,	
Ensayos 1 517 1 4535,	
aloinjertos 2 517 2 4534,5422,	
mediadas 1 517 1 4524,	
suprimiendo 1 517 1 4522,	
B 1 517 1 4521,	
directo 1 517 1 4512,	
linfocitos 1 517 1 4499,	
neto 1 517 1 4490,	
resulta 1 517 1 4476,	
ciclo 1 517 1 4470,	
progresión 1 517 1 4468,	
crítica 1 517 1 4465,	
quinasa 1 517 1 4464,	
(mTOR) 1 517 1 4462,	
mamíferos 1 517 1 4461,	
Rapamicina 1 517 1 4459,	
Diana 1 517 1 4456,	
Molécula 1 517 1 4455,	
12-sirolimus 1 517 1 4449,	
FKPB 1 517 1 4448,	
complejo 1 517 1 4447,	
FKPB-12 1 517 1 4443,	
	"Comprimido 1 517 1 6980,	
une 1 517 1 4437,	
experimental 1 517 1 4432,	
di-(2- 1 517 1 6572,	
fertilidad 1 517 1 6414,	
± 5 517 5 5480,5574,5582,5589,5594,	
evidencia 1 517 1 4431,	
mecanismo 1 517 1 4419,	
demuestran 1 517 1 4411,	
Ciertos 1 517 1 4409,	
independientes 1 517 1 4406,	
dependientes 2 517 2 4404,4613,	
intracelulares 1 517 1 4403,	
señales 2 517 2 4402,4487,	
(mínimo 1 517 1 6841,	
transducción 2 517 2 4400,4485,	
citosólica 1 517 1 4441,	
estímulos 1 517 1 4394,	
inducida 1 517 1 4388,	
T 2 517 2 4387,4519,	
activación 4 517 4 4383,4452,4496,4515,	
A10 1 517 1 4379,	
ATC 1 517 1 4377,	
Código 1 517 1 4376,	
selectivos 1 517 1 4375,	
farmacoterapéutico 1 517 1 4372,	
Grupo 1 517 1 4371,	
farmacodinámicas 1 517 1 4370,	
conservar 1 517 1 6682,	
Propiedades 2 517 2 4369,5384,	
ESTE 1 517 1 4365,	
PROPIEDADES 1 517 1 4362,	
cantidad 4 517 4 4358,5779,6773,6782,	
dializable 1 517 1 4355,	
será 1 517 1 4354,	
eritrocitos 1 517 1 4343,	
alta 3 517 3 4339,4738,5226,	
acuosa 1 517 1 4335,	
baja 3 517 3 4333,4868,5178,	
soporte 1 517 1 4328,	
sobredosificación 1 517 1 4309,	
general 1 517 1 4304,	
150 1 517 1 4299,	
ingestión 1 517 1 4297,	
manipulación 1 517 1 6762,	
auricular 1 517 1 4293,	
unión 1 517 1 4340,	
episodio 2 517 2 4290,4741,	
experimentó 1 517 1 4288,	
paciente 3 517 3 4287,4683,6680,	
Un 1 517 1 4286,	
sobredosis 2 517 2 4285,4323,	
Sobredosis 1 517 1 4278,	
meses) 1 517 1 4275,	
nevera 1 517 1 6659,	
36 5 517 5 4274,4675,4802,4842,5515,	
post-transplante 1 517 1 4273,	
mediana 3 517 3 4270,4940,5115,	
60 5 517 5 4269,4805,4890,6713,6806,	
brazo 3 517 3 4262,5276,5357,	
agudo 5 517 5 4254,4744,5062,5257,5314,	
serios 1 517 1 4250,	
ml/min 1 517 1 4238,	
basal 1 517 1 4233,	
filtrado 1 517 1 4231,	
90) 1 517 1 4226,	
subgrupo 4 517 4 4221,5204,5241,5283,	
cesó 1 517 1 4216,	
ng/ml) 1 517 1 4206,	
­ 1 517 1 4204,	
(niveles 1 517 1 4200,	
evalúa 1 517 1 4186,	
marcha 1 517 1 4184,	
SHU/PTT/MAT 1 517 1 4173,	
biliar) 1 517 1 4104,	
ureteral 1 517 1 4103,	
conductos 1 517 1 4101,	
vascular 1 517 1 4098,	
ejemplo 2 517 2 4095,6449,	
(por 2 517 2 4094,6448,	
quirúrgica 1 517 1 4090,	
fascial 1 517 1 4088,	
cirugía 1 517 1 4083,	
anormal 1 517 1 4079,	
proporcionalmente 1 517 1 4067,	
suspensión 1 517 1 4061,	
resolvió 1 517 1 4052,	
inmunosupresoras 1 517 1 4041,	
terapias 1 517 1 4040,	
pulmonar) 1 517 1 4032,	
fibrosis 1 517 1 4031,	
idiopática) 1 517 1 4029,	
(BONO 1 517 1 4028,	
organizativa 1 517 1 4027,	
idiopática 1 517 1 4024,	
obliterante 1 517 1 4023,	
bronquiolitis 1 517 1 4022,	
raramente 1 517 1 4021,	
neumonitis 1 517 1 4019,	
intersticial 2 517 2 4013,4050,	
aparecido 1 517 1 4009,	
Han 1 517 1 4008,	
mortal 1 517 1 4001,	
necrosis 1 517 1 3999,	
raros 2 517 2 3997,6349,	
hepatotoxicidad 1 517 1 3980,	
particular 1 517 1 3967,	
REVISIÓN 1 517 1 6917,	
complementarias 1 517 1 3953,	
etiología 1 517 1 4015,	
Exploraciones 1 517 1 3952,	
lugar 1 517 1 3949,	
generales 2 517 2 3944,4329,	
urinarios 1 517 1 3942,	
renales 2 517 2 3940,5423,	
musculoesqueléticos 1 517 1 3934,	
subcutáneo 1 517 1 3932,	
tejido 2 517 2 3931,3937,	
Erupción 1 517 1 3928,	
Acné 1 517 1 3927,	
mediastínicos 1 517 1 3920,	
glomerular) 1 517 1 5981,	
torácicos 1 517 1 3918,	
respiratorios 2 517 2 3917,4102,	
vasculares 1 517 1 3915,	
cardiacos 1 517 1 3913,	
hepatobiliares 1 517 1 3900,	
Trastornos 12 517 12 3891,3899,3901,3905,3912,3914,3916,3921,3923,3933,3939,3943,	
pólipos) 1 517 1 3890,	
quistes 1 517 1 3888,	
(incl 1 517 1 3887,	
especificadas 1 517 1 3886,	
malignas 1 517 1 3883,	
agitar 1 517 1 6851,	
benignas 1 517 1 3882,	
realizará 1 517 1 6752,	
Neoplasias 1 517 1 3881,	
Linfoma 1 517 1 3879,	
interrumpió 1 517 1 5014,	
Cáncer 1 517 1 3876,	
infestaciones 1 517 1 3874,	
Infecciones 1 517 1 3872,	
1/10 1 517 1 3869,	
000 2 517 2 3866,3870,	
1/1 1 517 1 3865,	
(parámetros 1 517 1 5597,	
experimentaron 1 517 1 4601,	
< 3 517 3 3862,3867,3871,	
1/100 1 517 1 3861,	
( 4 517 4 3858,3860,3864,3868,	
sistemas 1 517 1 3857,	
Raras 1 517 1 3854,	
Frecuentes 1 517 1 3851,	
Muy 1 517 1 3849,	
Clasificación 1 517 1 3847,	
administrando 1 517 1 3839,	
regímenes 1 517 1 3836,	
causal 1 517 1 3822,	
razonable 1 517 1 3819,	
sospecha 2 517 2 3818,4350,	
existe 1 517 1 3814,	
Sólo 1 517 1 3806,	
gravedad 1 517 1 3799,	
decreciente 1 517 1 3797,	
orden 1 517 1 3796,	
comercialización 1 517 1 3789,	
post- 1 517 1 3788,	
realizados 1 517 1 3783,	
últimos 1 517 1 3780,	
frecuencia 3 517 3 3775,3805,5087,	
clasificación 1 517 1 3769,	
enumeran 2 517 2 3794,3808,	
resumen 1 517 1 3761,	
tabla 1 517 1 3759,	
siguiente 1 517 1 3758,	
conforme 2 517 2 3748,3985,	
incrementarse 2 517 2 3747,3984,	
(LDH) 1 517 1 3737,	
deshidrogenasa 1 517 1 3736,	
lactato 1 517 1 3735,	
diarrea 1 517 1 3730,	
artralgia 1 517 1 3728,	
abdominal 1 517 1 3724,	
hipertrigliceridemia 1 517 1 3722,	
incrementada 1 517 1 5273,	
hiperglucemia 1 517 1 3721,	
hipercolesterolemia 1 517 1 3720,	
urinario 1 517 1 3719,	
intolerancia 2 517 2 9580,9590,	
tracto 1 517 1 3718,	
plasmáticas 1 517 1 4346,	
anemia 1 517 1 3713,	
>10% 1 517 1 3706,	
01 1 517 1 5581,	
(ocurren 1 517 1 3704,	
notificadas 1 517 1 3703,	
avance 1 517 1 6274,	
frecuentes 3 517 3 3702,3850,3853,	
Reacciones 1 517 1 3696,	
realizado 1 517 1 3681,	
máquinas 2 517 2 3677,3693,	
utilizar 2 517 2 3676,3692,	
conducir 2 517 2 3674,3690,	
capacidad 2 517 2 3672,3688,	
Efectos 1 517 1 3669,	
(versección 1 517 1 3664,	
interrumpir 2 517 2 3662,4132,	
reversibles 3 517 3 3660,4130,6430,	
esperma 2 517 2 3643,4113,	
alteraciones 3 517 3 3638,3946,4108,	
interrumpida 1 517 1 3631,	
adversas 7 517 7 3624,3697,3700,3764,3792,5077,6193,	
provocar 1 517 1 3622,	
L04A 1 517 1 4378,	
potencial 1 517 1 3618,	
vacuolación 1 517 1 6222,	
humana 2 517 2 3615,5739,	
excreta 1 517 1 3611,	
radioactividad 2 517 2 3601,5770,	
detectó 1 517 1 3600,	
lactantes 2 517 2 3598,3626,	
ratas 7 517 7 3597,6303,6370,6416,6422,6459,6467,	
ulcerosas 1 517 1 6358,	
Después 5 517 5 3589,4779,5386,5750,6638,	
eficaz 1 517 1 3588,	
claramente 1 517 1 3565,	
embarazo 1 517 1 3559,	
humanos 1 517 1 3552,	
jeringa 3 517 3 6718,6766,6788,	
seres 1 517 1 3551,	
Berkshire 1 517 1 6873,	
desconoce 1 517 1 3547,	
utilizarse 3 517 3 3556,3584,6819,	
3) 3 517 3 3545,3666,4137,	
reproductiva 1 517 1 3541,	
toxicidad 2 517 2 3540,6404,	
mostrado 1 517 1 3539,	
estudios 6 517 6 3535,3682,4410,5286,5372,6402,	
embarazadas 1 517 1 3533,	
cutáneas 3 517 3 4897,5172,6357,	
mujeres 1 517 1 3532,	
utilización 1 517 1 3528,	
suficientes 1 517 1 3525,	
existen 1 517 1 3523,	
lactancia 2 517 2 3521,3628,	
Embarazo 1 517 1 3519,	
trimetoprim/sulfametoxazol 1 517 1 3516,	
prednisolona 1 517 1 3514,	
nifedipino 1 517 1 3513,	
metilprednisolona 1 517 1 3512,	
glibenclamida 1 517 1 3511,	
digoxina 1 517 1 3510,	
atorvastatina 1 517 1 3509,	
aciclovir 1 517 1 3508,	
significativas 1 517 1 3499,	
observado 3 517 3 3495,3637,4107,	
metoclopramida 1 517 1 3491,	
cisaprida 1 517 1 3489,	
gastrointestinales 2 517 2 3487,3922,	
polisorbato 1 517 1 6562,	
procinéticos 1 517 1 3486,	
observarse 1 517 1 3481,	
Pueden 1 517 1 3480,	
evitado 1 517 1 3479,	
mediado 2 517 2 3471,5952,	
afecta 2 517 2 3468,5949,	
pomelo 4 517 4 3467,5948,6536,6826,	
intestinales 1 517 1 3457,	
células 7 517 7 3456,4386,4518,6226,6264,6278,6453,	
disminuir 1 517 1 3450,	
gp-P 1 517 1 3448,	
reciben 1 517 1 3440,	
observadas 2 517 2 3436,6195,	
elevadas 1 517 1 3433,	
producir 1 517 1 3427,	
sacarosa 1 517 1 9564,	
desequilibrio 1 517 1 5030,	
necesarias 1 517 1 3425,	
isoenzimas 1 517 1 3418,	
1/10) 2 517 2 3859,3863,	
actividad 2 517 2 3415,5748,	
inhiba 1 517 1 3413,	
vivo 3 517 3 3409,4571,6288,	
espera 1 517 1 3406,	
CYP3A4/5 1 517 1 3403,	
CYP2C19 1 517 1 3400,	
CYP2C9 1 517 1 3399,	
P450 2 517 2 3398,5703,	
microsomal 1 517 1 3397,	
hepático 1 517 1 3396,	
citocromo 2 517 2 3395,5702,	
vitro 2 517 2 3393,6256,	
in 4 517 4 3392,3408,6255,6287,	
fenitoína) 1 517 1 3388,	
fenobarbital 1 517 1 3387,	
anticonvulsivos 1 517 1 3385,	
perforatum) 1 517 1 3384,	
Juan 1 517 1 3382,	
San 1 517 1 3381,	
Hierba 1 517 1 3379,	
proteasa) 1 517 1 3360,	
cimetidina 1 517 1 3356,	
rutas 1 517 1 4482,	
bromocriptina 1 517 1 3355,	
troleandomicina; 1 517 1 3352,	
antibióticos 1 517 1 3351,	
antifúngicos 1 517 1 3348,	
(DEHP) 1 517 1 6574,	
nicardipina; 1 517 1 3346,	
calcio 2 517 2 3345,4408,	
bloqueantes 1 517 1 3340,	
ej 3 517 3 3339,3378,9595,	
(p 3 517 3 3338,3377,9594,	
débiles 1 517 1 3323,	
moderados 1 517 1 3321,	
gastrointestinal 1 517 1 6234,	
(1 2 517 2 5197,6512,	
posibles 1 517 1 3318,	
plazo 1 517 1 3313,	
afectar 1 517 1 3302,	
decidió 1 517 1 4877,	
puedan 1 517 1 3301,	
posibilidad 1 517 1 3294,	
interacciones 4 517 4 3286,3317,3482,3496,	
resultados 4 517 4 3267,3289,5603,7533,	
Aunque 2 517 2 3265,3389,	
linfático 1 517 1 3898,	
etinilestradiol 1 517 1 3264,	
norgestrel/0 1 517 1 3260,	
0 3 517 3 3256,5650,5674,	
significativa 5 517 5 3252,4359,4697,4787,5611,	
(6-120 1 517 1 4996,	
orales 2 517 2 3244,5475,	
específica 1 517 1 4442,	
eritromicina 2 517 2 3164,3212,	
neumopatía 2 517 2 4012,4049,	
Eritromicina 1 517 1 3154,	
medicaciones 2 517 2 3153,3242,	
farmacocinéticas 4 517 4 3287,3483,3497,5385,	
ambas 2 517 2 3152,3241,	
adecuadas 2 517 2 3148,3239,	
crónicas 1 517 1 6359,	
reducciones 4 517 4 3147,3236,6428,6438,	
t 3 517 3 3132,3183,3206,	
S-(-) 1 517 1 3125,	
plasma 3 517 3 3124,3215,5512,	
Tanto 1 517 1 3115,	
fármacos 2 517 2 3093,3180,	
0PH 1 517 1 6875,	
verapamilo 2 517 2 3077,3122,	
Verapamilo 1 517 1 3067,	
desmetildiltiazem 1 517 1 3046,	
desacetildiltiazem 1 517 1 3044,	
metabolitos 2 517 2 3043,5724,	
envase 2 517 2 6600,6705,	
aumentaron 8 517 8 3023,3105,3126,3193,3216,6068,6114,6354,	
pacientes) 1 517 1 3709,	
tmáx 1 517 1 3020,	
acné 1 517 1 3729,	
diltiazem 3 517 3 3009,3039,3050,	
120 2 517 2 3006,6843,	
simultánea 2 517 2 2996,5438,	
marzo 2 517 2 6900,6910,	
11 3 517 3 2973,5652,5991,	
incrementa 2 517 2 2962,3987,	
días) 1 517 1 2958,	
100 1 517 1 2951,	
n=226) 1 517 1 5660,	
(400 1 517 1 2943,	
múltiples 3 517 3 2938,3074,3161,	
(una 1 517 1 2928,	
Voriconazol 1 517 1 2916,	
9 3 517 3 2900,4277,6885,	
4; 2 517 2 2895,3025,	
Tmáx 1 517 1 2888,	
refleja 1 517 1 2879,	
(inhibidor 5 517 5 2852,2917,2990,3068,3155,	
Ketoconazol 1 517 1 2851,	
co- 1 517 1 2841,	
pesos 1 517 1 6441,	
71 1 517 1 2834,	
deseados 1 517 1 4201,	
% 14 517 14 2831,2835,5447,5745,5872,5904,5970,5973,6071,6075,6086,6117,6121,6132,	
82 1 517 1 2830,	
Cmáx 4 517 4 2827,2887,3019,5942,	
chino 1 517 1 6269,	
Diltiazem 1 517 1 2989,	
redujo 4 517 4 2788,2822,6083,6129,	
tenían 2 517 2 4617,4625,	
repetidas 4 517 4 2785,2859,5428,5476,	
(inductor 1 517 1 2778,	
administrar 2 517 2 2768,6591,	
afectó 5 517 5 2759,2862,3010,3035,3082,	
sanos 7 517 7 2750,2961,5410,5759,5849,6092,6141,	
policloruro 1 517 1 6578,	
voluntarios 3 517 3 2749,5758,5848,	
Una 1 517 1 2742,	
Medicamentos 1 517 1 6937,	
afectadas 1 517 1 2741,	
administró 1 517 1 2721,	
tmax 3 517 3 2718,3096,5578,	
Cmax 8 517 8 2715,2732,2964,3095,3117,3182,3204,5570,	
Reino 1 517 1 6876,	
incrementos 1 517 1 2712,	
reflejó 1 517 1 2709,	
respectivamente 10 517 10 2701,2836,2902,2975,3032,3114,3202,3225,6076,6122,	
listados 1 517 1 4312,	
80% 1 517 1 2700,	
141% 1 517 1 2698,	
183% 1 517 1 2697,	
AUC 13 517 13 2693,2735,2824,2890,2967,3022,3099,3120,3187,3210,5944,6062,6108,	
produjeron 1 517 1 2689,	
10 6 517 6 2678,2802,2899,2998,4360,6913,	
2h 1 517 1 2671,	
normativas 1 517 1 6757,	
(300 3 517 3 2664,2675,2687,	
simultáneamente 2 517 2 2661,2751,	
administrados 3 517 3 2660,2670,7521,	
A 6 517 6 2654,4670,4689,4888,5164,6055,	
incrementados 1 517 1 2650,	
grado 4 517 4 2642,2868,3088,3175,	
tasa 11 517 11 2640,2866,3085,3172,4229,4245,4735,4792,5169,5978,6568,	
Rifampicina 1 517 1 2777,	
CYP3A4) 7 517 7 2638,2780,2854,2919,2992,3070,3157,	
(sustrato 1 517 1 2636,	
Ciclosporina 1 517 1 2635,	
4) 7 517 7 2634,2850,2915,2988,3974,5149,5348,	
testículos 2 517 2 6232,6444,	
incrementan 3 517 3 2590,2604,3750,	
motivo 2 517 2 5958,6584,	
disminuyen 2 517 2 2584,2610,	
afectan 1 517 1 2568,	
consecución 1 517 1 6158,	
sustancias 3 517 3 2566,3354,3507,	
proteína 1 517 1 4440,	
influenciadas 1 517 1 2563,	
posterior 2 517 2 2557,4080,	
delgado 1 517 1 2551,	
intestino 1 517 1 2550,	
excluir 1 517 1 3292,	
situada 1 517 1 2547,	
P 2 517 2 2545,5709,	
preparación 1 517 1 6647,	
glicoproteína 2 517 2 2544,5708,	
multifármaco 1 517 1 2543,	
flujo 2 517 2 2542,3452,	
bomba 1 517 1 2540,	
sustrato 2 517 2 2537,5700,	
isoenzima 1 517 1 2531,	
intestinal 1 517 1 2524,	
eu 1 517 1 6943,	
metabolizado 1 517 1 2520,	
sacarasa 1 517 1 9576,	
medicamentos 2 517 2 2511,9602,	
Interacción 1 517 1 2507,	
asociados 4 517 4 2499,4174,6485,9553,	
(SHU/PTT/MAT) 2 517 2 2498,9552,	
microangiopatía 2 517 2 2496,9550,	
trombótica 4 517 4 2494,2497,9548,9551,	
urémico 2 517 2 2490,9544,	
hemolítico 2 517 2 2489,9543,	
síndrome 2 517 2 2488,9542,	
Incompatibilidades 1 517 1 6527,	
2% 3 517 3 2437,4777,9491,	
final 1 517 1 5465,	
nefrótico) 3 517 3 2434,5159,9488,	
(síndrome 3 517 3 2433,5158,9487,	
nefrosis 3 517 3 2432,5157,9486,	
aparición 3 517 3 2430,5155,9484,	
notificó 3 517 3 2427,5152,9481,	
común 2 517 2 2400,9454,	
rasgo 2 517 2 2399,9453,	
observó 4 517 4 2397,3247,6409,9451,	
calcineurina 17 517 17 2386,2462,2482,2504,4167,4179,4197,4986,5141,5196,5252,5335,5367,9440,9516,9536,9558,	
conversión 10 517 10 2381,2418,2458,4193,4980,5096,5183,9435,9472,9512,	
evaluación 2 517 2 2378,9432,	
estudio 11 517 11 2376,2442,3270,4182,4951,4966,5208,6420,6463,9430,9496,	
urinarias 5 517 5 2373,2408,5270,9427,9462,	
proteínas 8 517 8 2372,2407,2571,4345,5218,5269,9426,9461,	
excreción 6 517 6 2370,2405,5216,5267,9424,9459,	
periódico 2 517 2 2367,9421,	
cuantitativo 2 517 2 2366,9420,	
control 2 517 2 2365,9419,	
realizar 2 517 2 2363,9417,	
recuperación 3 517 3 2356,4152,9410,	
dolor 1 517 1 3723,	
retrasar 3 517 3 2354,4150,9408,	
continuada 2 517 2 2332,9386,	
coadministración 2 517 2 2331,9385,	
recomendarse 3 517 3 2329,7111,9383,	
seguían 2 517 2 2324,9378,	
neoplasia 2 517 2 2317,9371,	
Poco 1 517 1 3852,	
incidencia 4 517 4 2315,3741,4893,9369,	
así 3 517 3 2309,4861,9363,	
altas 4 517 4 2304,5317,5324,9358,	
éxito 2 517 2 2291,9345,	
excluyendo 1 517 1 4728,	
retiró 3 517 3 2289,4596,9343,	
controles 2 517 2 2280,9334,	
absorbe 1 517 1 5396,	
comparación 10 517 10 2269,2319,4716,4913,5326,6026,6088,6134,9323,9373,	
calculada 7 517 7 2267,2308,4797,4962,5223,9321,9362,	
glomerular 6 517 6 2266,2307,4232,4795,9320,9361,	
filtración 6 517 6 2265,2306,4794,5980,9319,9360,	
bajas 2 517 2 2263,9317,	
tasas 8 517 8 2261,2302,5059,5254,5311,5319,9315,9356,	
altos 3 517 3 2256,5125,9310,	
TITULAR 1 517 1 6859,	
tuvieron 5 517 5 2253,2294,5310,9307,9348,	
tratados 8 517 8 2240,2273,3647,4117,5296,5330,9294,9327,	
precaución 2 517 2 2237,9291,	
tenerse 2 517 2 2236,9290,	
perjudicial 2 517 2 2230,9284,	
usarse 2 517 2 6649,6769,	
conocidos 2 517 2 2225,9279,	
coadministran 2 517 2 2222,9276,	
sérica 7 517 7 2210,2259,2300,4620,9264,9313,9354,	
creatinina 7 517 7 2209,2258,2299,4619,9263,9312,9353,	
formas 1 517 1 2514,	
Producto 2 517 2 2185,9239,	
Características 2 517 2 2183,9237,	
Resúmenes 2 517 2 2180,9234,	
respectivos 2 517 2 2179,9233,	
descritos 2 517 2 2176,9230,	
media 3 517 3 4789,5112,5454,	
anticonceptivo 3 517 3 3280,3306,3587,	
adversos 5 517 5 2175,3745,4249,4307,9229,	
efectos 9 517 9 2174,3657,3685,3744,4127,4248,4306,4414,9228,	
rabdomiólisis 2 517 2 2171,9225,	
fibrato 2 517 2 2161,9215,	
(hidroxi-metil-glutaril)- 1 517 1 2156,	
HMG 2 517 2 2155,9211,	
inhibidor 7 517 7 2152,2479,4164,5333,5365,9208,9533,	
administra 3 517 3 2150,3049,9206,	
les 3 517 3 2149,4923,9205,	
tolerada 2 517 2 2137,9193,	
fibratos 2 517 2 2133,9189,	
reductasa 4 517 4 2131,2158,9187,9213,	
(Hypericum 1 517 1 3383,	
CoA 3 517 3 2130,2157,9186,	
HMG- 2 517 2 2129,9185,	
continuar 2 517 2 2111,9167,	
reevaluarse 2 517 2 2107,9163,	
refractaria 2 517 2 2105,9161,	
riesgo/beneficio 4 517 4 2096,2109,9152,9165,	
iniciar 2 517 2 2087,9143,	
establecida 2 517 2 2084,9140,	
lípidos 2 517 2 2079,9135,	
reductores 2 517 2 2077,9133,	
(EMEA) 1 517 1 6938,	
ejercicio 2 517 2 2074,9130,	
dieta 2 517 2 2073,9129,	
adoptarse 2 517 2 2070,9126,	
detectase 2 517 2 2067,9123,	
tests 2 517 2 2061,9116,	
hiperlipidemia 8 517 8 2059,2068,2083,2104,9114,9124,9139,9160,	
monitorizados 6 517 6 2055,2164,3143,3232,9110,9218,	
reciban 2 517 2 2051,9106,	
requerir 2 517 2 2046,9101,	
colesterol 2 517 2 2040,9095,	
séricos 2 517 2 2038,9093,	
(CYP3A4) 1 517 1 5705,	
reclutamiento 2 517 2 4218,5016,	
mg) 4 517 4 2665,2676,2688,2933,	
CMV 2 517 2 2018,9073,	
enfermedad 2 517 2 2016,9071,	
especialmente 2 517 2 2009,9064,	
(CMV) 2 517 2 2001,9056,	
citomegalovirus 2 517 2 2000,9055,	
	5 1 517 1 4367,	
max 3 517 3 3133,3184,3207,	
carinii 4 517 4 1973,1987,9028,9042,	
Pneumocystis 4 517 4 1972,1986,9027,9041,	
neumonía 6 517 6 1970,1983,4026,4252,9025,9038,	
antimicrobiana 4 517 4 1964,1980,9019,9035,	
medios 3 517 3 5632,6060,6106,	
protección 2 517 2 1956,9011,	
factor 2 517 2 1954,9009,	
protectoras 2 517 2 1948,9003,	
prendas 2 517 2 1947,9002,	
fibrilación 1 517 1 4292,	
usando 2 517 2 1946,9001,	
sujetos 5 517 5 2960,4881,5409,6091,6140,	
UV 2 517 2 1945,9000,	
luz 5 517 5 1939,1944,6675,8994,8999,	
global 1 517 1 5057,	
exposición 5 517 5 1936,2873,5907,6206,8991,	
cáncer 2 517 2 1930,8985,	
4% 1 517 1 4929,	
padecer 2 517 2 1929,8984,	
(CsA) 1 517 1 2655,	
Como 2 517 2 1918,8973,	
angioneurótico 2 517 2 1917,8972,	
tipo 3 517 3 1914,6710,8969,	
radiomarcado 1 517 1 3595,	
desencadenado 2 517 2 1911,8966,	
angiotensina) 2 517 2 1909,8964,	
convertidora 2 517 2 1907,8962,	
enzima 2 517 2 1906,8961,	
(inhibidores 2 517 2 1903,8958,	
IECA 2 517 2 1902,8957,	
raras 2 517 2 1894,8949,	
vasculitis 2 517 2 1886,8941,	
dermatitis 2 517 2 1883,8938,	
angioedema 2 517 2 1882,8937,	
anafilácticas/anafilactoides 2 517 2 1881,8936,	
incluían 1 517 1 4043,	
hipersensibilidad 4 517 4 1878,1888,8933,8943,	
leve 1 517 1 6049,	
reacciones 14 517 14 1876,1880,1912,3623,3699,3763,3791,3810,4523,5076,6192,8931,8935,8967,	
asociado 4 517 4 1870,2031,8925,9086,	
inmunosupresor 4 517 4 1859,2090,8914,9146,	
parte 3 517 3 1855,5764,8910,	
fructosa 1 517 1 9583,	
resultando 2 517 2 1844,8899,	
bronquial 2 517 2 1843,8898,	
vieron 2 517 2 2648,2740,	
anastomosis 2 517 2 1842,8897,	
significativos 2 517 2 1824,8879,	
celular 1 517 1 4471,	
hemodinámicamente 2 517 2 1823,8878,	
túbulos) 1 517 1 6457,	
derrames 2 517 2 1822,8877,	
(incluyendo 4 517 4 1821,4018,4726,8876,	
pleural 2 517 2 1817,8872,	
	Prospectos 1 517 1 9600,	
derrame 4 517 4 1816,1819,8871,8874,	
linfedema 2 517 2 1815,8870,	
periférico 3 517 3 1814,3727,8869,	
acumulación 2 517 2 1809,8864,	
También 5 517 5 1803,2425,5150,8858,9479,	
anómala 2 517 2 1800,8855,	
post-aleatorización 1 517 1 4768,	
placebo 2 517 2 2277,9331,	
presentarmayor 1 517 1 1797,	
kg/m2 2 517 2 1795,8848,	
superior 2 517 2 1792,8845,	
IMC 2 517 2 1791,8844,	
médica 2 517 2 1786,8839,	
hernia 1 517 1 4089,	
bibliografía 2 517 2 1785,8838,	
Basándose 3 517 3 1779,4330,8832,	
dehiscencia 6 517 6 1776,1839,4087,4092,8829,8894,	
linfocele 3 517 3 1774,3725,8827,	
heridas 7 517 7 1767,1778,1802,4097,8820,8831,8857,	
cicatrización 5 517 5 1765,1799,4078,8818,8854,	
casos 17 517 17 1758,1807,1837,1968,3655,3978,3996,4010,4047,4076,4125,4321,6347,8811,8862,8892,9023,	
notificado 12 517 12 1757,1806,1836,1967,2922,3977,3995,4075,8810,8861,8891,9022,	
muerte 6 517 6 1754,4259,5067,5262,5321,8807,	
injerto 12 517 12 1751,2351,4147,4257,4645,4680,4702,4855,5065,5260,8804,9405,	
Anticonceptivos 1 517 1 3243,	
pérdida 7 517 7 1749,4255,4643,4730,5063,5258,8802,	
desembocando 2 517 2 1744,8797,	
(HAT) 2 517 2 1743,8796,	
33 1 517 1 6085,	
controlar 2 517 2 2166,9220,	
arteria 2 517 2 1741,8794,	
trombosis 2 517 2 1738,8791,	
incremento 7 517 7 1736,2034,2402,2691,8789,9089,9456,	
tacrolimus 3 517 3 1731,4425,8784,	
están 3 517 3 1710,4415,8763,	
pulmón 4 517 4 1702,1867,8755,8922,	
hígado 5 517 5 1700,1723,2528,8753,8776,	
inmunosupresora 3 517 3 1693,5749,8746,	
establecido 4 517 4 1684,2451,8737,9505,	
sepsis 2 517 2 1680,8733,	
	6 1 517 1 6497,	
mortales 5 517 5 1677,1848,4036,8730,8903,	
oportunistas 2 517 2 1674,8727,	
infección 2 517 2 1670,8723,	
aumentar 5 517 5 1665,3331,3366,3459,8718,	
inmune 3 517 3 1662,4528,8715,	
sistema 5 517 5 1661,3897,3903,4527,8714,	
excesiva 2 517 2 1659,8712,	
significativamente 13 517 13 2649,2863,3011,3083,3170,4736,4808,4866,4899,4948,5123,5176,5315,	
supresión 2 517 2 1658,8711,	
triglicéridos 2 517 2 2043,9098,	
8) 6 517 6 1656,1892,5039,5163,8709,8947,	
inmunosupresión 8 517 8 1652,2219,3838,3955,4505,6367,8705,9273,	
piel 8 517 8 1645,1932,3878,3926,3970,4938,8698,8987,	
particularmente 2 517 2 1642,8695,	
tumores 4 517 4 1641,3965,6332,8694,	
desarrollo 5 517 5 1635,2169,3960,8688,9223,	
infecciones 7 517 7 1631,1673,1676,3716,8684,8726,8729,	
susceptibilidad 5 517 5 1629,1667,3958,8682,8720,	
diálisis 2 517 2 4615,5966,	
rifabutina) 3 517 3 1622,2603,8675,	
rifampicina 6 517 6 1621,2601,2787,2811,2846,8674,	
claritromicina) 3 517 3 1616,2583,8669,	
itraconazol 3 517 3 1613,2580,8666,	
ketoconazol 5 517 5 1611,2578,2861,2911,8664,	
FARMACOLÓGICAS 1 517 1 4363,	
(tales 6 517 6 1609,1619,2576,2599,8662,8672,	
trombocitopénica 2 517 2 2493,9547,	
potentes 3 517 3 1606,2624,8659,	
co-administración 6 517 6 1601,2619,2907,2925,2980,8654,	
macho) 1 517 1 6320,	
estables 3 517 3 1589,5424,8642,	
alcancen 2 517 2 1587,8640,	
prolongado 2 517 2 1581,8634,	
hipocalemia 1 517 1 3714,	
periodo 3 517 3 1580,5619,8633,	
volumen 1 517 1 6839,	
prolonga 2 517 2 1559,8612,	
Dado 3 517 3 1553,3616,8606,	
reducción 10 517 10 1529,1542,2312,4055,5869,5975,6477,8581,8594,9366,	
SL6 1 517 1 6874,	
atenuadas 2 517 2 1497,8548,	
vacunas 2 517 2 1496,8547,	
evitar 2 517 2 1492,8543,	
efectiva 3 517 3 1489,5487,8540,	
incluyendo 13 517 13 1482,1671,1773,1879,2091,4086,4251,5726,8533,8724,8826,8934,9147,	
Durante 7 517 7 1477,2138,2189,3567,8528,9194,9243,	
vacunación 4 517 4 1476,1485,8527,8536,	
respuesta 3 517 3 1473,6381,8524,	
variar 2 517 2 1471,8522,	
novo 8 517 8 1463,1719,1865,5295,5363,8513,8772,8920,	
marco 2 517 2 1458,8508,	
Ac) 2 517 2 1452,8502,	
CYP2D6 1 517 1 3401,	
(IL-2R 2 517 2 1451,8501,	
bajos 2 517 2 2297,9351,	
IL-2 4 517 4 1450,5309,5344,8500,	
receptor 4 517 4 1448,5307,5342,8498,	
frente 2 517 2 1446,8496,	
posteriores 4 517 4 1431,2415,8481,9469,	
obtenida 2 517 2 1427,8477,	
extensamente 3 517 3 1415,2519,8465,	
Sirolimus 11 517 11 1410,2517,2533,3033,4072,4380,5698,5710,5731,6244,8460,	
citotóxicos 2 517 2 1409,8459,	
anticuerpos 4 517 4 1408,1445,8458,8495,	
mofetil 6 517 6 1405,1437,5009,5300,8455,8487,	
micofenolato 6 517 6 1404,1436,5008,5299,8454,8486,	
azatioprina 5 517 5 1403,2282,5010,8453,9336,	
púrpura 2 517 2 2492,9546,	
administrado 2 517 2 1396,8446,	
inmunosupresores 13 517 13 1389,1421,1469,1481,3846,4374,4429,5006,6341,8439,8471,8520,8532,	
agentes 19 517 19 1388,1401,1420,2076,2188,2224,3347,3485,3845,4373,4428,5005,6340,8438,8451,8470,9132,9242,9278,	
concomitante 12 517 12 1385,1898,2122,2192,2474,4159,5003,8435,8953,9178,9246,9528,	
estratificado 1 517 1 4956,	
alto 5 517 5 1376,2013,5853,8426,9068,	
adecuadamente 2 517 2 1371,8421,	
estudiado 4 517 4 1370,1414,8420,8464,	
(24 1 517 1 6697,	
especiales 5 517 5 1363,6552,6654,6727,8413,	
precauciones 2 517 2 1362,8412,	
Advertencias 2 517 2 1360,8410,	
activo 3 517 3 1351,3412,8401,	
principio 3 517 3 1350,3411,8400,	
Hipersensibilidad 2 517 2 1348,8398,	
material 1 517 1 6802,	
Contraindicaciones 2 517 2 1347,8397,	
5) 4 517 4 1344,1626,8394,8679,	
interaccionar 2 517 2 1338,8388,	
exfoliativa 2 517 2 1884,8939,	
productos 2 517 2 1332,8382,	
(microemulsión) 4 517 4 1329,2765,2776,8379,	
consideraciones 2 517 2 1324,8374,	
Otras 3 517 3 1323,3316,8373,	
acuerdo 4 517 4 1309,3777,6754,8359,	
realizarse 2 517 2 1307,8357,	
equivalentes 3 517 3 1299,5937,8349,	
elevado 3 517 3 1957,4641,9012,	
convertidas 2 517 2 1297,8347,	
desconocida 1 517 1 4017,	
sido 5 517 5 1296,3659,4129,6344,8346,	
utilizando 4 517 4 1291,2060,8341,9115,	
medidas 5 517 5 1290,2071,4326,8340,9127,	
ficha 2 517 2 1287,8337,	
indican 2 517 2 1284,8334,	
Todas 2 517 2 1277,8327,	
medicinales 4 517 4 1333,1336,8383,8386,	
relaciona 2 517 2 1268,8318,	
fabricante 2 517 2 1266,8316,	
referencia 4 517 4 1261,1276,8311,8326,	
registrado 2 517 2 1256,8306,	
inmunoensayo 2 517 2 1255,8305,	
método 5 517 5 1253,1273,3586,8303,8323,	
solar 4 517 4 1940,1952,8995,9007,	
use 2 517 2 1251,8301,	
Cuando 5 517 5 1249,2220,2719,8299,9274,	
intercambiables 2 517 2 1248,8298,	
técnicas 2 517 2 1245,8295,	
mediante 3 517 3 1243,4395,8293,	
animales 3 517 3 3537,4507,6202,	
obtenidos 5 517 5 1242,5534,5833,6138,8292,	
inmunoensayos 2 517 2 1237,8287,	
Agencia 1 517 1 6934,	
mide 2 517 2 1230,8280,	
clínica 3 517 3 1222,6399,8272,	
práctica 2 517 2 1221,8271,	
medir 2 517 2 1211,8261,	
utilizado 5 517 5 1205,1852,6738,8255,8907,	
dosificaciones 1 517 1 7910,	
sugiere 2 517 2 3282,4433,	
han 27 517 27 1204,1295,1756,1805,1835,1869,1966,2450,3494,3538,3636,3658,3680,3976,3994,4074,4106,4128,6343,8254,8345,8809,8860,8890,8924,9021,9504,	
cromatográficos 8 517 8 1202,1234,1293,1300,8252,8284,8343,8350,	
Hubo 3 517 3 4243,4733,6031,	
métodos 8 517 8 1201,1207,1233,1292,8251,8257,8283,8342,	
basan 2 517 2 1199,8249,	
24 8 517 8 1194,2413,4673,4801,5144,6627,8244,9467,	
recomendados 4 517 4 1188,1711,8238,8764,	
intervalos 3 517 3 1187,5985,8237,	
semivida 6 517 6 1185,1561,5464,5486,8235,8614,	
prolongación 3 517 3 1182,6144,8232,	
produce 3 517 3 1179,6153,8229,	
estacionario 3 517 3 1176,6161,8226,	
Período 1 517 1 6614,	
alimentos 1 517 1 5918,	
alcanzar 3 517 3 1173,5893,8223,	
retraso 8 517 8 1171,1762,2346,4142,6155,8221,8815,9400,	
estable 4 517 4 1168,5472,5498,8218,	
muestren 2 517 2 1165,8215,	
7 8 517 8 1157,2971,3223,3668,5505,5646,6858,8207,	
medirse 2 517 2 1149,8199,	
la(s) 2 517 2 1127,8177,	
Las 8 517 8 1111,3698,3790,5058,5075,5253,6191,8161,	
24% 1 517 1 3136,	
deberá 1 517 1 1106,	
adición 2 517 2 1096,8145,	
debido 5 517 5 1093,1169,5027,8142,8219,	
mL/min 5 517 5 4968,5026,5049,5110,5213,	
excede 2 517 2 1089,8138,	
estimada 2 517 2 1088,8137,	
40 6 517 6 1082,1091,4237,5584,8131,8140,	
exceder 2 517 2 1080,8129,	
(PVC) 1 517 1 6581,	
diaria 4 517 4 1077,1087,8126,8136,	
máxima 2 517 2 1074,8123,	
mantenimiento- 2 517 2 1067,8116,	
(nueva 2 517 2 1064,8113,	
03 1 517 1 3261,	
3x 2 517 2 1063,8112,	
retirada 2 517 2 4633,4925,	
Dosis 2 517 2 1057,8106,	
considerablemente 2 517 2 1051,8100,	
incrementar 5 517 5 1050,2484,4169,8099,9538,	
carga 14 517 14 1046,1059,1101,1105,1130,1147,1566,8095,8108,8150,8154,8180,8197,8619,	
(287 1 517 1 6029,	
considerarse 8 517 8 1042,2094,2212,3146,3235,8091,9150,9266,	
Además 3 517 3 1034,4574,8083,	
actual) 4 517 4 1033,1071,8082,8120,	
disminuyó 1 517 1 3134,	
deseada/concentración 2 517 2 1031,8081,	
(concentración 2 517 2 1030,8080,	
actual 4 517 4 1028,1223,8078,8273,	
nueva 7 517 7 1022,1037,2429,5154,8072,8086,9483,	
proporción 2 517 2 1020,8070,	
simple 2 517 2 1019,8069,	
ciclosporina) 2 517 2 1006,8056,	
(tras 2 517 2 1001,8051,	
(gp-P) 1 517 1 2546,	
adicionales 2 517 2 997,8047,	
requieren 2 517 2 995,8045,	
mediados 1 517 1 4416,	
Si 6 517 6 988,1084,3047,6676,8038,8133,	
eliminación 13 517 13 984,2558,4555,4656,4712,4752,4819,4873,6554,6729,6734,6764,8034,	
corresponder 2 517 2 979,8029,	
aumenta 6 517 6 973,3956,4066,5459,6566,8023,	
velocidad 4 517 4 968,982,8018,8032,	
consecuencia 1 517 1 5080,	
inmunosupresiva 2 517 2 958,8008,	
aumento 6 517 6 954,3732,5884,5901,6306,8004,	
limitarse 2 517 2 1934,8989,	
veces) 4 517 4 951,966,8001,8016,	
(incremento 4 517 4 948,963,7998,8013,	
interacción 5 517 5 946,2516,3249,3272,7996,	
ausencia 4 517 4 944,960,7994,8010,	
mayor 10 517 10 938,1628,1926,4246,5763,6009,7988,8681,8851,8981,	
veces 12 517 12 937,2820,2901,2974,3031,3113,3129,3201,3224,5462,5888,7987,	
necesitará 2 517 2 934,7984,	
recibían 3 517 3 1771,5542,8824,	
medio 3 517 3 929,6001,7979,	
término 2 517 2 928,7978,	
Por 6 517 6 927,1974,2552,6582,7977,9029,	
incremente 2 517 2 922,7972,	
multicéntrico 1 517 1 4953,	
interrumpa 2 517 2 917,7967,	
zumo 8 517 8 3465,5927,5946,6534,6547,6811,6824,6848,	
descenderán 2 517 2 912,7962,	
consiguiente 2 517 2 907,7957,	
metabolismo 9 517 9 902,2586,2606,3329,3368,3470,3907,5951,7951,	
inhibe 5 517 5 900,3391,4381,4450,7949,	
Tras 3 517 3 876,5448,7925,	
anterior 2 517 2 875,7866,	
cambio 5 517 5 872,1569,7863,7903,8622,	
hepatocelular 1 517 1 6316,	
aumentos 1 517 1 2882,	
días 10 517 10 867,1110,1124,1158,5506,6622,7858,8160,8174,8208,	
obtenido 2 517 2 863,7854,	
nivel 4 517 4 861,3989,4069,7852,	
único 2 517 2 860,7851,	
basarse 4 517 4 855,1016,7846,8066,	
deben 23 517 23 854,1117,1148,1306,1572,2053,2069,2162,3051,3141,3145,3230,3234,4324,6818,7845,8167,8198,8356,8625,9108,9125,9216,	
ajustes 8 517 8 848,996,1014,1302,7839,8046,8064,8352,	
manera 4 517 4 845,2100,7836,9156,	
jeringas 2 517 2 6625,6721,	
De 4 517 4 844,2097,7835,9153,	
leche 2 517 2 3604,3614,	
alimento 2 517 2 839,7830,	
consecuentemente 2 517 2 835,7826,	
nutrición 1 517 1 3911,	
relación 4 517 4 821,3821,5508,7812,	
tomarse 2 517 2 816,7807,	
consecutivos 2 517 2 1164,8214,	
variabilidad 3 517 3 813,6034,7804,	
minimizar 2 517 2 811,7802,	
laboratorio 4 517 4 809,2063,7800,9118,	
parámetros 7 517 7 807,3641,4111,5530,5616,6163,7798,	
CL/F/W 1 517 1 5592,	
solubilidad 1 517 1 4334,	
tisulares 2 517 2 805,7796,	
biopsias 2 517 2 804,7795,	
(FG) 1 517 1 4796,	
aumentó 2 517 2 2812,3169,	
signos/síntomas 2 517 2 802,7793,	
prestar 2 517 2 796,7787,	
ajustar 2 517 2 789,7780,	
base 8 517 8 787,1423,3213,4834,4958,7778,7886,8473,	
única 7 517 7 786,2744,2800,2929,3275,5754,7777,	
especial 4 517 4 776,798,7767,7789,	
necesidad 4 517 4 772,957,7763,8007,	
telitromicina 3 517 3 1614,2581,8667,	
tengan 2 517 2 771,7762,	
mTOR 1 517 1 4475,	
probable 2 517 2 767,7758,	
elimina 2 517 2 762,7753,	
notablemente 2 517 2 759,7750,	
carbamazepina 1 517 1 3386,	
reduce 2 517 2 758,7749,	
) 9 517 9 1383,2447,5882,5898,6611,8433,8518,8605,9501,	
(3) 2 517 2 751,7742,	
C) 3 517 3 6103,6637,6665,	
y/o 9 517 9 750,2132,2160,5716,6445,6605,7741,9188,9214,	
5); 2 517 2 749,7740,	
interrupción 7 517 7 745,878,1003,3580,7736,7927,8053,	
conjuntamente 4 517 4 740,1397,7731,8447,	
administran 2 517 2 739,7730,	
CYP3A4 13 517 13 737,1608,2532,2575,2598,2626,2630,3325,3364,3473,5954,7728,8661,	
inhibidores 23 517 23 735,1605,2126,2384,2460,2501,2573,2623,3320,3358,3446,4176,4195,4984,5139,5193,5249,7726,8658,9182,9438,9514,9555,	
inductores 7 517 7 733,1618,2596,2628,3362,7724,8671,	
(2) 2 517 2 731,7722,	
historial 1 517 1 9572,	
hepática; 2 517 2 730,7721,	
presentaninsuficiencia 1 517 1 729,	
(1) 2 517 2 725,7715,	
poblaciones 5 517 5 724,770,6171,7714,7761,	
siguientes 12 517 12 723,1400,1992,2006,3506,3577,4845,6221,7713,8450,9047,9061,	
extracción 1 517 1 6570,	
estrechamente 2 517 2 713,7703,	
Deben 2 517 2 711,7701,	
monitorización 4 517 4 700,778,7690,7769,	
óptima 4 517 4 697,846,7687,7837,	
cromatográfico) 4 517 4 694,897,7684,7946,	
ensayo 15 517 15 693,1209,1312,4551,5564,5605,5640,5658,5682,6259,6272,6286,7683,8259,8362,	
valores 13 517 13 691,1239,1270,2885,3017,5656,5680,6059,6105,6137,7681,8289,8320,	
(expresado 2 517 2 689,7679,	
objetivo 7 517 7 683,888,1305,7673,7923,7937,8355,	
aparentemente 2 517 2 2135,9191,	
concentraciones 16 517 16 673,1053,1112,1279,1319,1588,2790,3422,5493,5815,7663,8102,8162,8329,8369,8641,	
horas 15 517 15 667,826,1195,2683,2723,2755,2771,2947,2955,5418,5546,6628,7657,7817,8245,	
recibieron 10 517 10 661,1832,1962,4564,4815,5412,5426,7651,8887,9017,	
mayoría 10 517 10 656,1009,1746,3652,3829,4122,4391,7646,8059,8799,	
danazol 1 517 1 3357,	
fármaco 7 517 7 654,706,781,3277,7644,7696,7772,	
modificar 2 517 2 644,7634,	
necesario 7 517 7 643,1049,3062,3566,6678,7633,8098,	
cuidadosamente 4 517 4 627,1511,7618,8563,	
controlado 1 517 1 4955,	
monitorizar 6 517 6 626,1118,1510,7617,8168,8562,	
aproximadamente 7 517 7 618,2695,2817,2828,5444,5460,7609,	
mitad 4 517 4 617,1537,7608,8589,	
reducir 4 517 4 608,3327,3370,7599,	
primera 1 517 1 6896,	
grave 7 517 7 605,1136,1525,6099,7596,8186,8577,	
función 20 517 20 594,1539,2200,2233,2349,2359,3766,4145,4155,4627,4859,5051,5350,6173,7585,8591,9254,9287,9403,9413,	
alteración 4 517 4 591,1760,7582,8813,	
pared 1 517 1 2523,	
reducido 2 517 2 587,7578,	
diferencia 5 517 5 2757,4695,4781,4850,5610,	
aclaramiento 5 517 5 582,1544,2814,7573,8596,	
hepática 21 517 21 580,595,604,623,1135,1507,1524,1742,4000,6048,6098,6152,6240,7571,7586,7595,7614,8185,8559,8576,8795,	
ajuste 7 517 7 567,1139,2214,3064,7558,8189,9268,	
ningún 3 517 3 566,6800,7557,	
(fosfatidilcolina 1 517 1 6507,	
requiere 4 517 4 565,698,7556,7688,	
insuficiencia 18 517 18 561,579,603,622,1134,1506,1523,6047,6097,6151,7552,7570,7594,7613,7720,8184,8558,8575,	
822) 3 517 3 556,5839,7516,	
= 9 517 9 555,1026,1062,4225,4268,5838,7515,8076,8111,	
(n 5 517 5 554,4224,4267,5837,7514,	
adulta 3 517 3 547,5836,7507,	
producida 2 517 2 1984,9039,	
población 3 517 3 546,5835,7506,	
similares 8 517 8 541,5069,5264,5830,6168,6207,7501,7534,	
hipofosfatemia 1 517 1 3715,	
35 4 517 4 531,5820,5903,7491,	
jóvenes 3 517 3 523,5811,7483,	
rápidamente 1 517 1 5397,	
diferente 4 517 4 519,4420,5806,7479,	
responder 4 517 4 516,940,7476,7990,	
clotrimazol 1 517 1 3349,	
podrían 2 517 2 515,7475,	
determinar 5 517 5 512,1317,5802,7472,8367,	
años 17 517 17 510,539,553,5074,5167,5232,5800,5825,5844,5992,5998,6618,7470,7499,7513,7531,7547,	
hidroxidesmetil 1 517 1 5730,	
65 11 517 11 509,538,552,5799,5824,5843,7469,7498,7512,7530,7546,	
> 6 517 6 507,536,5797,5822,7467,7496,	
canales 1 517 1 3343,	
número 4 517 4 503,4650,5793,7463,	
incluyeron 4 517 4 501,4576,5791,7461,	
clínicos 18 517 18 497,803,1392,1430,1715,2119,3782,4536,5287,5787,6198,6210,7455,7794,8442,8480,8768,9175,	
ensayos 15 517 15 496,1391,1429,1714,2118,3781,4654,5786,6197,6249,7454,8441,8479,8767,9174,	
Los 37 517 37 495,524,1186,1238,1301,1468,2048,2238,2283,2572,2595,3016,3137,3226,3319,3361,3445,3534,4636,5529,5629,5785,5812,6162,6360,7453,7484,7517,7867,8236,8288,8351,8519,9103,9292,9337,9559,	
(>65 2 517 2 493,7451,	
avanzada 2 517 2 492,7450,	
edad 6 517 6 491,5846,5987,6015,6043,7449,	
2) 13 517 13 486,574,599,843,1552,1596,5696,7444,7565,7590,7834,8604,8649,	
apartado 41 517 41 484,572,597,747,841,1342,1380,1465,1624,1654,1890,2422,2444,2632,2848,2913,2986,3543,3972,4135,4240,5037,5147,5161,5346,5694,6608,6643,7442,7563,7588,7738,7832,8392,8430,8515,8677,8707,8945,9476,9498,	
limitada 4 517 4 480,4283,6400,7438,	
disponible 3 517 3 478,6927,7436,	
farmacocinética 8 517 8 477,947,2761,3037,3250,3299,7435,7997,	
recomendar 2 517 2 466,7424,	
experiencia 4 517 4 464,3787,4282,7422,	
suficiente 6 517 6 463,504,4651,5794,7421,7464,	
hay 4 517 4 462,3285,4280,7420,	
No 25 517 25 461,563,641,1597,1681,2327,2448,2615,2837,2903,2976,3245,3492,3522,3605,3678,5607,7091,7419,7554,7631,8650,8734,9381,9502,	
años) 4 517 4 460,494,7418,7452,	
riesgode 1 517 1 1798,	
18 8 517 8 459,550,5841,5997,7417,7510,7544,8554,	
(< 2 517 2 458,7416,	
adolescentes 4 517 4 457,474,7415,7432,	
bloqueo 2 517 2 4397,4479,	
niños 8 517 8 455,472,482,1826,7413,7430,7440,8881,	
específicas 3 517 3 441,4483,7399,	
recomendaciones 2 517 2 440,7398,	
trombocitopenia 1 517 1 3712,	
permitir 2 517 2 439,7397,	
limitados 2 517 2 437,7395,	
seguridad 10 517 10 434,1686,2453,4188,4975,5035,6190,7392,8739,9507,	
datos 9 517 9 430,525,1782,3524,4839,5813,7388,7485,8835,	
Actualmente 3 517 3 428,4279,7386,	
observa 2 517 2 418,7376,	
eficacia 11 517 11 415,432,1688,2455,3304,4190,4977,7373,7390,8741,9509,	
elevados 5 517 5 408,2207,4007,7366,9261,	
fluconazol; 1 517 1 3350,	
requieran 2 517 2 401,7360,	
(predominantemente 2 517 2 399,7358,	
transplante 23 517 23 394,534,1460,1698,1721,1863,2008,2027,2394,4085,4213,5470,5827,7321,7353,7494,7526,8510,8751,8774,8918,9063,9082,	
indique 2 517 2 389,7348,	
escasa 2 517 2 386,7345,	
Hay 2 517 2 385,7344,	
usos 2 517 2 1708,8761,	
negra 8 517 8 384,398,427,452,7343,7357,7385,7410,	
raza 8 517 8 383,397,426,451,7342,7356,7384,7409,	
receptores 9 517 9 381,392,449,1717,4577,7340,7351,7407,8770,	
alternativo 2 517 2 378,7337,	
inmunosupresivo 2 517 2 377,7336,	
justificar 1 517 1 4631,	
e 8 517 8 373,1901,2589,3873,4405,5729,7332,8956,	
clínicamente 4 517 4 369,3251,3498,7328,	
apropiado 4 517 4 368,2215,7327,9269,	
resulte 2 517 2 367,7326,	
mayoritario 1 517 1 5735,	
intentarse 2 517 2 345,7304,	
resultado 6 517 6 341,1649,4489,4503,7300,8702,	
da 3 517 3 340,4501,7299,	
abandono 2 517 2 334,7293,	
En 63 517 63 327,363,600,619,1131,1219,1390,1422,1503,1520,1712,1893,1958,2080,2116,2202,2342,2374,3650,3756,4045,4120,4138,4180,4303,4318,4506,4833,5040,5101,5202,5284,5368,5718,5847,5961,6044,6094,6352,6369,6401,6418,6466,6623,7286,7322,7591,7610,8181,8269,8440,8472,8555,8572,8765,8948,9013,9136,9172,9256,9396,9428,9567,	
administrarse 5 517 5 324,1107,1977,7283,9032,	
ajustarse 2 517 2 302,7261,	
semanas 5 517 5 295,3576,6425,7254,7900,	
8 9 517 9 294,2446,2957,3695,3875,4317,6878,7253,9500,	
equivalente) 2 517 2 279,7238,	
vs 3 517 3 4775,4930,4969,	
técnica 4 517 4 278,1288,7237,8338,	
delfármaco) 1 517 1 7630,	
o 61 517 61 277,337,342,734,760,837,868,1122,1142,1294,1334,1352,1567,1615,1617,1701,1730,1752,1761,2075,2278,2582,2602,2627,2752,3040,4059,4572,4623,5916,6056,6283,6537,6546,6794,6810,6847,7104,7236,7296,7301,7725,7751,7828,7859,7907,8172,8192,8344,8384,8402,8620,8668,8670,8754,8783,8805,8814,9131,9332,9597,	
naranja 4 517 4 5929,6549,6813,6850,	
anastomótica 1 517 1 4093,	
monoclonal 2 517 2 276,7235,	
150-400 2 517 2 273,7232,	
son 11 517 11 271,424,435,1247,3430,3710,4310,7230,7382,7393,8297,	
primeros 3 517 3 266,5091,7225,	
2- 2 517 2 264,7223,	
concentración 22 517 22 258,527,703,1167,1191,1213,1225,1241,5403,5453,5875,5895,7217,7487,7693,7895,7917,8217,8241,8263,8275,8291,	
edema 5 517 5 1813,1916,3726,8868,8971,	
sugerido 2 517 2 256,7215,	
intervalo 10 517 10 255,682,887,1304,3803,7214,7672,7922,7936,8354,	
esteroides 2 517 2 250,7209,	
disminución 3 517 3 248,6411,7207,	
régimen 9 517 9 246,376,1858,2217,4667,7205,7335,8913,9271,	
fármaco) 5 517 5 237,321,640,7196,7280,	
cambios 2 517 2 3296,6361,	
terapéutica 12 517 12 235,319,638,652,704,779,7194,7278,7629,7642,7694,7770,	
Monitorización 8 517 8 234,318,637,651,7193,7277,7628,7641,	
cromatográfico 6 517 6 232,316,1274,7191,7275,8324,	
(ensayo 8 517 8 231,275,315,896,7190,7234,7274,7945,	
ng/ml 14 517 14 230,274,314,688,895,5577,5648,5672,5677,7189,7233,7273,7678,7944,	
12 21 517 21 229,311,687,892,1990,2946,2954,3575,4203,4672,4771,4800,5572,5697,5995,7188,7270,7523,7677,7941,9045,	
total 23 517 23 225,309,635,679,720,1216,1228,1519,2795,3104,3192,5637,5720,5738,5908,7184,7268,7626,7669,7710,8266,8278,8571,	
sangre 31 517 31 224,308,634,678,719,1215,1227,1518,2794,3058,3103,3191,3335,3374,3739,3894,5456,5510,5528,5636,5719,5737,5880,7183,7267,7625,7668,7709,8265,8277,8570,	
valle 36 517 36 222,259,306,405,630,674,862,890,1054,1113,1163,1192,1320,1514,3753,3990,4004,4070,5631,5816,7181,7218,7265,7364,7621,7664,7853,7896,7918,7939,8103,8163,8213,8242,8370,8566,	
niveles 41 517 41 221,305,404,629,715,909,1151,1162,1513,1575,2037,2206,2254,2295,2592,2612,3054,3138,3227,3333,3372,3461,3752,4003,5630,6204,6388,7180,7264,7363,7620,7705,7959,8201,8212,8565,8628,9092,9260,9308,9349,	
obtener 4 517 4 220,304,7179,7263,	
monitorizarse 7 517 7 712,1573,2198,3052,7702,8626,9252,	
individualizarse 2 517 2 217,7176,	
día 5 517 5 211,2950,5668,5692,7170,	
vez 4 517 4 209,6833,6857,7168,	
seguida 2 517 2 204,7163,	
después 26 517 26 201,268,360,668,742,827,864,1125,2672,2684,2772,2796,4294,5093,5501,5552,5626,7160,7227,7319,7658,7733,7818,7855,7901,8175,	
inhibición 3 517 3 3429,4473,4493,	
posible 7 517 7 200,1634,2168,6213,7159,8687,9222,	
sea 6 517 6 199,1048,3564,6544,7158,8097,	
pronto 2 517 2 197,7156,	
administrada 4 517 4 195,2747,7154,8157,	
inducción 6 517 6 190,648,1443,7149,7638,8493,	
dosis 79 517 79 188,213,298,402,570,610,646,754,831,924,931,975,1000,1023,1027,1038,1044,1065,1068,1073,1086,1099,1103,1128,1141,1145,1532,1564,1571,2743,2784,2799,2858,2930,2939,3066,3075,3150,3162,3238,3274,3441,4058,5413,5427,5474,5554,5663,5687,5753,7147,7172,7257,7361,7561,7601,7636,7745,7822,7974,7981,8025,8050,8073,8077,8087,8093,8114,8117,8122,8135,8148,8152,8178,8191,8195,8584,8617,8624,	
infecciosa 1 517 1 4016,	
usual 4 517 4 183,1920,7142,8975,	
dosificación 9 517 9 182,775,851,874,5378,7141,7766,7842,7865,	
pauta 3 517 3 180,5376,7139,	
La 55 517 55 179,212,238,283,475,655,695,777,898,967,1021,1072,1327,1627,1657,2639,2781,2810,2855,2993,3071,3094,3158,3181,3203,3740,3828,3954,4430,4472,4592,4788,5349,5429,5463,5507,6143,6733,6765,6920,7138,7171,7197,7242,7433,7645,7685,7768,7947,8017,8071,8121,8377,8680,8710,	
post-transplante) 2 517 2 178,7137,	
(2 3 517 3 174,5780,7133,	
asoció 2 517 2 1733,8786,	
inicial 2 517 2 173,7132,	
Terapia 4 517 4 172,280,7131,7239,	
Uso 14 517 14 169,379,453,487,557,575,1384,7128,7338,7411,7445,7548,7566,8434,	
trasplantes 2 517 2 168,7127,	
cualificado 2 517 2 166,7125,	
apropiadamente 2 517 2 165,7124,	
especialista 2 517 2 164,7123,	
dirección 2 517 2 161,7120,	
iniciarse 5 517 5 156,374,4325,7115,7333,	
debe 54 517 54 155,216,242,285,301,323,353,370,783,795,815,978,1041,1079,1259,1491,1933,1976,2093,2106,2197,2211,2235,3477,3555,3583,3629,5959,6530,6648,6768,7114,7175,7201,7244,7260,7282,7312,7329,7774,7786,7806,8028,8090,8128,8309,8542,8988,9031,9149,9162,9251,9265,9289,	
tratamiento 25 517 25 154,1479,1500,2047,2089,2113,3310,3569,3634,3825,4264,4669,4721,4828,4982,5082,5098,5278,5359,7113,8530,8551,9102,9145,9169,	
El 18 517 18 153,254,581,2019,2472,2702,3464,4064,4157,4488,5001,5924,5945,7112,7213,7572,9074,9526,	
exclusivamente 2 517 2 149,7087,	
efecto 4 517 4 2229,2703,4511,9283,	
x 2 517 2 1029,8079,	
administración 24 517 24 146,1873,1897,2121,2191,2727,2782,2842,2856,2936,2994,3072,3159,3592,3951,5389,5437,5450,6606,7084,8928,8952,9177,9245,	
forma 6 517 6 144,518,5056,5807,7082,7478,	
adultos) 2 517 2 1828,8883,	
Posología 2 517 2 142,7080,	
1) 6 517 6 139,1467,2424,4242,7077,9478,	
5 43 517 43 138,485,573,598,842,866,1155,1381,1466,1551,1595,2159,2423,2506,2656,2666,2818,2819,3128,3544,3665,4136,4241,4361,5382,5503,5689,5887,5989,6185,6700,7076,7443,7564,7589,7833,7857,8205,8431,8516,8603,8648,9477,	
desmetil 1 517 1 5728,	
secciones 6 517 6 134,1547,1591,7072,8599,8644,	
(ver 49 517 49 133,483,571,596,636,746,840,1341,1379,1464,1545,1590,1623,1653,1889,2421,2443,2631,2847,2912,2985,3542,3971,4134,4239,5036,5146,5160,5345,5693,6607,6642,7070,7441,7562,7587,7627,7737,7831,8391,8429,8514,8597,8643,8676,8706,8944,9475,9497,	
62 1 517 1 5479,	
20 5 517 5 313,894,4205,7272,7943,	
progresivamente 4 517 4 132,287,7069,7246,	
sólo 2 517 2 125,7062,	
mantenimiento 23 517 23 122,282,612,993,1040,1070,1534,2341,2392,2468,4209,4761,4992,7059,7241,7603,8043,8089,8119,8586,9395,9446,9522,	
biodisponibilidad 3 517 3 3013,5861,7096,	
terapia 18 517 18 120,239,696,791,881,991,1692,2140,2339,7057,7198,7686,7782,7930,8041,8745,9196,9393,	
mantenerse 6 517 6 118,158,354,7055,7117,7313,	
meses 27 517 27 115,177,267,359,1991,2005,2252,2414,4588,4676,4692,4772,4806,4843,4891,4997,5092,5145,5625,7052,7136,7226,7318,9046,9060,9306,9468,	
período 8 517 8 110,290,2247,4767,6694,7047,7249,9301,	
durante 28 517 28 108,288,355,989,1498,1578,1988,2002,2245,2948,2956,3308,3557,3573,3632,4584,4765,5088,5617,7045,7247,7314,8039,8549,8631,9043,9057,9299,	
corticosteroides 14 517 14 107,124,326,1406,1439,5012,5302,5337,5551,7044,7061,7285,8456,8489,	
microemulsión 7 517 7 105,129,253,5544,7042,7066,7212,	
ciclosporina 73 517 73 104,128,252,261,284,336,349,671,756,824,833,883,899,915,962,987,1328,1402,1729,2196,2242,2275,2293,2326,2334,2653,2663,2674,2686,2706,2730,2764,2775,4424,4593,4635,4714,4725,4755,4764,4821,4832,4875,4887,4911,4927,5440,5543,7041,7065,7211,7220,7243,7295,7308,7661,7747,7815,7824,7932,7948,7965,8012,8037,8378,8452,8782,9250,9296,9329,9347,9380,9388,	
combinación 10 517 10 102,347,1417,1441,3842,5435,7039,7306,8467,8491,	
inicialmente 2 517 2 100,7037,	
utilice 5 517 5 99,1315,6598,7036,8365,	
indica 1 517 1 5516,	
recomienda 27 517 27 95,607,625,885,1455,1509,1527,1599,1996,2362,2617,2767,2839,2905,2978,5911,7032,7598,7616,7892,7934,8505,8561,8579,8652,9051,9416,	
Se 32 517 32 94,794,1203,1490,1755,1834,1868,1995,2361,2766,2920,3546,3635,3975,3993,4073,4105,4537,5013,5866,5910,6436,7031,7785,7891,8253,8541,8808,8889,8923,9050,9415,	
lactosa 1 517 1 9566,	
renal 36 517 36 93,395,535,562,1461,2028,2201,2234,2360,2395,2471,4156,4214,4567,4628,4860,4995,5052,5293,5351,5471,5540,5828,6174,7030,7354,7495,7527,7553,8511,9083,9255,9288,9414,9449,9525,	
trasplante 17 517 17 92,203,270,362,1994,2470,4591,4994,5292,5539,5628,7029,7162,7229,9049,9448,9524,	
sometidos 9 517 9 89,1696,2025,3834,5964,6182,7026,8749,9080,	
inmunológico 7 517 7 88,1378,3904,4544,4640,7025,8428,	
riesgo 17 517 17 87,1377,1927,2014,2486,3549,3982,4065,4171,4543,4639,7024,8427,8852,8982,9069,9540,	
moderado 3 517 3 86,4548,7023,	
presentan 12 517 12 82,1375,1925,2205,2345,4141,7019,7719,8425,8980,9259,9399,	
normales 2 517 2 6093,6142,	
adultos 6 517 6 80,171,6028,7017,7130,7540,	
pacientes 130 517 130 79,329,365,421,489,506,522,532,559,577,589,601,620,659,710,727,1012,1132,1373,1504,1521,1557,1695,1769,1788,1830,1861,1923,1959,2011,2024,2049,2081,2102,2144,2203,2239,2272,2284,2322,2343,2390,2440,2466,3438,3646,3832,4038,4116,4139,4211,4223,4539,4562,4599,4637,4813,4824,4906,4919,4990,5021,5044,5105,5206,5234,5244,5290,5329,5420,5468,5537,5796,5810,5821,5962,6011,6020,6045,6095,6149,6351,7016,7288,7324,7379,7447,7466,7482,7492,7524,7539,7550,7568,7580,7592,7611,7649,7700,7717,7868,8062,8182,8423,8556,8573,8610,8748,8822,8841,8885,8916,8978,9014,9066,9079,9104,9137,9158,9200,9257,9293,9326,9338,9376,9397,9444,9494,9520,9569,	
órganos 4 517 4 77,3771,3855,7014,	
rechazo 9 517 9 75,4253,4532,4604,4743,5061,5256,5313,7012,	
profilaxis 8 517 8 73,1963,1979,1997,7010,9018,9034,9052,	
indicado 2 517 2 70,7007,	
está 4 517 4 69,6926,7006,7919,	
Rapamune 125 517 125 68,97,116,147,185,215,241,300,322,351,372,499,614,650,665,814,853,1025,1061,1076,1366,1435,1483,1502,1690,1772,1833,1853,2022,2052,2092,2115,2124,2142,2194,2244,2337,2388,2420,2464,2476,2769,2809,3004,3315,3444,3553,3571,3649,3663,3827,3840,4044,4063,4119,4133,4302,4348,4352,4559,4660,4708,4723,4816,4830,4885,4988,5100,5132,5185,5237,5280,5298,5361,5560,5789,5913,5935,6528,6558,6593,6776,6785,7005,7034,7053,7085,7144,7174,7200,7259,7281,7310,7331,7457,7520,7605,7640,7655,7805,7844,8075,8110,8125,8416,8485,8534,8553,8743,8825,8888,8908,9077,9107,9148,9171,9180,9198,9248,9298,9391,9442,9474,9518,9530,	
terapéuticas 3 517 3 67,3442,7004,	
pantalla 2 517 2 1951,9006,	
Indicaciones 2 517 2 66,7003,	
/ 5 517 5 2491,2495,3880,9545,9549,	
	4 2 517 2 64,7001,	
CLÍNICOS 2 517 2 63,7000,	
DATOS 3 517 3 62,6495,6999,	
fluidos 2 517 2 1811,8866,	
4 70 517 70 61,135,140,227,292,666,685,748,825,936,1123,1343,1345,1358,1359,1548,1592,1625,1655,1891,2445,2505,2633,2682,2754,2770,2849,2894,2897,2914,2987,3194,3195,3197,3199,3517,3667,3694,3973,4276,4316,4776,5038,5148,5162,5347,5695,6492,6652,6998,7073,7078,7186,7251,7656,7675,7739,7816,7986,8173,8393,8395,8408,8409,8600,8645,8678,8708,8946,9499,	
Huntercombe 1 517 1 6868,	
	Solución 1 517 1 59,	
FARMACÉUTICA 2 517 2 58,6979,	
FORMA 2 517 2 57,6978,	
debidos 1 517 1 6335,	
3 33 517 33 56,114,176,265,358,1032,1121,1161,1346,2004,2251,3027,3107,3220,3257,4553,4610,4931,5461,5580,5886,6186,6613,6977,7051,7135,7224,7317,8171,8211,8396,9059,9305,	
6 28 517 28 54,193,2411,2808,3030,3218,3518,4587,5090,5200,5575,5624,6493,6494,6525,6556,6557,6609,6610,6612,6644,6651,6699,6724,6725,6975,7152,9465,	
sección 5 517 5 53,4315,6491,6555,6974,	
mostraron 2 517 2 4847,6304,	
ver 6 517 6 52,233,317,6973,7192,7276,	
excipientes 5 517 5 51,1357,6501,6972,8407,	
completa 2 517 2 49,6970,	
lista 2 517 2 48,6969,	
abreviada 1 517 1 5379,	
linfoma 4 517 4 1637,3962,6280,8690,	
afroamericanos) 2 517 2 400,7359,	
consultar 2 517 2 46,6967,	
Para 6 517 6 45,810,4934,6814,6966,7801,	
Excipientes 2 517 2 44,6965,	
optimizarse 2 517 2 243,7202,	
sirolimus 124 517 124 43,410,446,470,529,584,632,676,717,793,904,911,926,933,977,1056,1115,1153,1197,1218,1281,1322,1340,1393,1516,1603,1727,1875,1900,2352,2560,2588,2594,2608,2614,2621,2646,2659,2669,2681,2737,2746,2792,2816,2844,2875,2892,2909,2927,2969,2982,3015,3056,3079,3101,3140,3166,3189,3229,3254,3337,3376,3390,3424,3454,3463,3501,3530,3594,3609,3620,3755,3992,4006,4148,4161,4199,4266,4435,4508,5394,5433,5458,5518,5533,5634,5818,5863,5878,6067,6113,6166,6468,6964,7368,7404,7428,7489,7575,7623,7666,7707,7784,7953,7961,7976,7983,8027,8105,8165,8203,8247,8268,8331,8372,8390,8443,8568,8656,8780,8930,8955,9406,9562,	
mg 29 517 29 41,194,207,663,1083,1092,2657,2667,2679,2803,2944,2952,2999,3007,3258,3262,4300,5558,5666,5690,6950,6962,7153,7166,7653,7888,7890,8132,8141,	
contiene 3 517 3 39,6561,6960,	
ml 3 517 3 38,6714,6807,	
	Cada 2 517 2 37,6958,	
CUANTITATIVA 2 517 2 36,6957,	
Y 2 517 2 35,6956,	
CUALITATIVA 2 517 2 34,6955,	
COMPOSICIÓN 2 517 2 33,6954,	
2 46 517 46 32,112,136,141,206,406,662,950,965,1109,1549,1593,2722,2932,3106,3111,3112,3200,5073,5166,5231,5285,5383,5417,5557,5573,5576,5583,5647,5665,5781,6515,6526,6617,6953,7049,7074,7079,7165,7652,7899,8000,8015,8159,8601,8646,	
conjuntivo 1 517 1 3938,	
oral 20 517 20 31,60,152,191,2806,2942,2995,3002,3081,3168,3281,3307,5393,5865,6560,6595,7090,7150,7459,7878,	
solución 11 517 11 30,2805,3001,3080,3167,5392,5561,6559,6594,7458,7877,	
mg/ml 1 517 1 29,	
	Rapamune 2 517 2 27,6948,	
MEDICAMENTO 3 517 3 26,4366,6947,	
interrumpirse 6 517 6 131,286,371,7068,7245,7330,	
NOMBRE 2 517 2 24,6945,	
atención 2 517 2 799,7790,	
1 34 517 34 22,23,28,40,55,65,1382,2896,2949,3024,3026,3029,3108,3109,3127,3196,3217,3219,3222,4368,5071,5229,5406,5766,6498,6944,6949,6961,6976,6995,7002,7897,8432,8517,	
PRODUCTO 1 517 1 21,	
DEL 4 517 4 20,25,6918,6946,	
grupo 11 517 11 4706,4719,4750,4759,4826,4871,4883,5128,5181,5189,6041,	
CARACTERÍSTICAS 1 517 1 19,	
LAS 1 517 1 18,	
DE 9 517 9 17,4364,6860,6863,6880,6882,6887,6891,6915,	
RESUMEN 1 517 1 16,	
O 1 517 1 15,	
absorción 5 517 5 2555,2644,2870,3090,3177,	
TÉCNICA 1 517 1 14,	
voriconazol 5 517 5 1612,2579,2941,2984,8665,	
FICHA 1 517 1 13,	
ocasiones 2 517 2 1895,8950,	
tuvo 2 517 2 672,7662,	
información 10 517 10 10,387,476,1264,1426,6921,7346,7434,8314,8476,	
Toda 1 517 1 8,	
medicamento 6 517 6 7,12,1577,6736,6925,8630,	
Basica 1 517 1 5,	
	Información 1 517 1 4,	
COMPRIMIDOS 1 517 1 3,	
pericárdico 2 517 2 1820,8875,	
30 6 517 6 2,1794,5969,6621,6720,8847,	
5MG 1 517 1 1,	
RAPAMUNE 1 517 1 0,	
